Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
Di Santo P, Mathew R, Jung RG, Simard T, Skanes S, Mao B, Ramirez FD, Marbach JA, Abdel-Razek O, Motazedian P, Parlow S, Boczar KE, D'Egidio G, Hawken S, Bernick J, Wells GA, Dick A, So DY, Glover C, Russo JJ, McGuinty C, Hibbert B; CAPITAL DOREMI investigators. Di Santo P, et al. Among authors: so dy. Crit Care. 2021 Aug 10;25(1):289. doi: 10.1186/s13054-021-03706-2. Crit Care. 2021. PMID: 34376218 Free PMC article. Clinical Trial.
A citywide protocol for primary PCI in ST-segment elevation myocardial infarction.
Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA, Davies RF, Sherrard HL, Maloney J, Marquis JF, O'Brien ER, Trickett J, Poirier P, Ryan SC, Ha A, Joseph PG, Labinaz M. Le May MR, et al. Among authors: so dy. N Engl J Med. 2008 Jan 17;358(3):231-40. doi: 10.1056/NEJMoa073102. N Engl J Med. 2008. PMID: 18199862 Free article.
Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST).
Le May MR, Wells GA, Glover CA, So DY, Froeschl M, Marquis JF, O'Brien ER, Turek M, Thomas A, Kass M, Jadhav S, Labinaz M. Le May MR, et al. Among authors: so dy. Circ Cardiovasc Interv. 2009 Aug;2(4):330-8. doi: 10.1161/CIRCINTERVENTIONS.108.847582.108.847582. Epub 2009 Jul 22. Circ Cardiovasc Interv. 2009. PMID: 20031736 Clinical Trial.
ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: Insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarction (CAPITAL AMI) trial.
So DY, Ha AC, Davies RF, Froeschl M, Wells GA, Le May MR. So DY, et al. Can J Cardiol. 2010 Jan;26(1):e7-12. doi: 10.1016/s0828-282x(10)70331-7. Can J Cardiol. 2010. PMID: 20101370 Free PMC article. Clinical Trial.
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial.
Roberts JD, Wells GA, Le May MR, Labinaz M, Glover C, Froeschl M, Dick A, Marquis JF, O'Brien E, Goncalves S, Druce I, Stewart A, Gollob MH, So DY. Roberts JD, et al. Among authors: so dy. Lancet. 2012 May 5;379(9827):1705-11. doi: 10.1016/S0140-6736(12)60161-5. Epub 2012 Mar 29. Lancet. 2012. PMID: 22464343 Clinical Trial.
Transradial versus transfemoral artery approach for coronary angiography and percutaneous coronary intervention in the extremely obese.
Hibbert B, Simard T, Wilson KR, Hawken S, Wells GA, Ramirez FD, Le May MR, So DY, Glover CA, Froeschl M, Marquis JF, Labinaz M, Dick A, O'Brien ER. Hibbert B, et al. Among authors: so dy. JACC Cardiovasc Interv. 2012 Aug;5(8):819-26. doi: 10.1016/j.jcin.2012.04.009. JACC Cardiovasc Interv. 2012. PMID: 22917453 Free article.
142 results